The Claim
Omega-3 fatty acid supplementation in patients with colorectal cancer is associated with significant reductions in circulating levels of the pro-inflammatory cytokines IL-6 and TNF-α, as well as C-reactive protein.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
In patients with colorectal cancer, taking omega-3 fatty acid supplements is linked to lower levels of IL-6, TNF-α, and C-reactive protein in the blood.
See the scientific wording
Omega-3 fatty acid supplementation in patients with colorectal cancer is associated with significant reductions in circulating levels of the pro-inflammatory cytokines IL-6 and TNF-α, as well as C-reactive protein, suggesting a modulatory effect on systemic inflammation.
Omega-3 fatty acids replace other fats in cell membranes, which changes how immune cells produce signaling molecules. Instead of making inflammatory signals, they make molecules that stop inflammation and help repair tissue. This reduces the release of inflammatory proteins into the blood, which in turn tells the liver to make less of another inflammation marker.
What the research says
1 studyTaking omega-3 fatty acids helped lower key inflammation markers in people with colorectal cancer, according to this study. This suggests omega-3s may help calm the body’s harmful inflammatory response.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.